Experimental Escherichia coli pyelonephritis: formation of spheroplasts in the kidney of the untreated rat.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D005455:Fluorescent Antibody Technique; D007106:Immune Sera / Q000032:analysis; D007740:L Forms / Q000472:pathogenicity*; D009113:Muramidase / Q000502:physiology; D009996:Osmotic Fragility; D009997:Osmotic Pressure; D011704:Pyelonephritis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D051381:Rats
D000900:Anti-Bacterial Agents; D007106:Immune Sera; D004917:Erythromycin; D009113:Muramidase